Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways
Type
Retraction
Notice date
7/19/2022 0:00
Journal
Medical Science Monitor: International Medical Journal of Experimental and Clinical Research